作为创业板疫苗第一股沃森生物,曾经相当辉煌,然而,如今的这家企业不仅出现巨额亏损,而且还因卷入当前的疫苗案遭遇停牌。作为创业板疫苗第一股,沃森生物昔日相当辉煌,以市盈率133倍、发行价95元的价格登陆创业板。然而,这起昔日明星2015年业绩显示如今不仅巨亏3亿,而且还卷入了近日的疫苗案件 The Watson Bio, the first GEM vaccine, was once quite brilliant. However, not only has the company suffered a huge loss today, it has also suffered a suspension of its involvement in the current vaccine. As the first unit of GEM vaccine, Watson biological past quite brilliant, price-earnings ratio of 133 times the issue price of 95 yuan landing GEM. However, this past star’s 2015 performance shows not only a huge loss of 300 million but also a recent case of vaccination